Both in R&D — Physical & Biological Sciences
MaxCyte vs Absci
Over the past year MXCT returned +10.3% and ABSI returned +170.0%; their daily moves had a correlation of 0.29.
MXCT +10.3% ABSI +170.0%Growth of $1, one year, split-adjusted
| Metric | MXCT | ABSI |
|---|---|---|
| Price | $1.71 | $11.88 |
| Market cap | $176.5M | $2.04B |
| Today | +11.04% | +12.39% |
| 1 month | +44.9% | +17.2% |
| 6 months | +109.1% | +152.2% |
| Year to date | +10.3% | +240.4% |
| 1 year | +11.0% | +164.0% |
| Revenue growth (YoY) | −14.5% | −46.4% |
| Gross margin | 77.0% | 100.0% |
| Net margin | −122.0% | −10443.4% |
| P/E (TTM) | — | — |
| Price / sales | 5.7× | 1,306.1× |
| Net cash | $105.7M | $201.0M |
| Dividend yield | — | — |
| Volatility (60d) | 78.8% | 95.6% |
| Short % of float | 2.0% | 31.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).